Quote | Sigyn Therapeutics Inc (OTCMKTS:SIGY)
Last: | $5.25 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $5.25 |
High: | $0 |
Low: | $0 |
Volume: | 5 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Sigyn Therapeutics Inc (OTCMKTS:SIGY)
Sigyn Therapeutics (OTCQB: SIGY) , a development-stage medical technology company, today announced financial results for the first quarter ended March 31, 2024. During the quarter, the company reported a loss from operations of $629,972, as compared to an operating loss of $521,258 for the compar...
SAN DIEGO, CA - ( NewMediaWire ) - May 15, 2024 - Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a development-stage medical technology company, today announced financial results for the first quarter ended March 31, 2024. During the quarter, the C...
Message Board Posts | Sigyn Therapeutics Inc (OTCMKTS:SIGY)
Subject | By | Source | When |
---|---|---|---|
seems a pump might be coming, unless it's | rhopton | investorshub | 03/10/2023 12:27:04 PM |
no idea I just saw it when you | PennyStockTrader2 | investorshub | 03/10/2023 12:22:31 PM |
what happened yesterday, more volume than the last | rhopton | investorshub | 03/10/2023 11:18:29 AM |
talk about dead money this has been, very | PennyStockTrader2 | investorshub | 01/09/2023 4:38:53 PM |
Sigyn Therapeutics - $SIGY Featured in PubCoInsight. | FinlayS00 | investorshub | 06/22/2022 6:44:57 PM |
News, Short Squeeze, Breakout and More Instantly...
Sigyn Therapeutics Inc Company Name:
SIGY Stock Symbol:
OTCMKTS Market:
Sigyn Therapeutics Inc Website:
Sigyn Therapeutics (OTCQB: SIGY) , a development-stage medical technology company, today announced financial results for the first quarter ended March 31, 2024. During the quarter, the company reported a loss from operations of $629,972, as compared to an operating loss of $521,258 for the compar...
SAN DIEGO, CA - ( NewMediaWire ) - May 15, 2024 - Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a development-stage medical technology company, today announced financial results for the first quarter ended March 31, 2024. During the quarter, the C...
Sigyn Therapeutics (OTCQB: SIGY) , a development-stage medical technology company, today announced that it has published an article entitled: “Sigyn Therapy(TM), an Emerging Candidate to Address Endotoxemia, Sepsis and Drug-Resistant Viral & Bacterial Infections.” “Wh...